May 3 |
Phathom a buy at Stifel on new heartburn therapy
|
Apr 29 |
Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
|
Apr 19 |
MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
|
Apr 19 |
12 Most Shorted Stocks in 2024
|
Apr 7 |
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
|
Apr 5 |
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
Apr 3 |
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 26 |
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
|
Mar 18 |
Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion
|
Mar 8 |
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript
|